Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2025P A Herzen Journal of Oncology

The place of stereotactic radiotherapy in the treatment of renal cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

IKI.V. KornilovACA.V. ChernichenkoNVN. V. Vorobyev

Discussion

Loading...

Member takes

Overview

Review reveals strong efficacy of stereotactic body radiotherapy for renal cancer, highlighting its potential as a surgical alternative.

Key Points

  • Stereotactic body radiotherapy shows high efficacy, achieving excellent local control rates and improved overall survival in patients with renal cancer.
  • Evidence from recent multicenter consortia recommends this therapy, particularly benefiting those who cannot undergo surgery.
  • Retrospective and prospective studies suggest it offers good tolerability while preserving renal function in functionally inoperable patients.
  • SBRT could be a promising option for treating renal cell carcinoma, especially in select patient populations facing surgical challenges.

Cite This Study

Kornilov et al. (2025) studied this question.

synapsesocial.com/papers/68af35e9cf1dd9ea359ea4fchttps://doi.org/10.17116/onkolog20251404186
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stereotactic body radiotherapy for lung cancer: a review2025
  2. 2Comprehensive Evaluation of Treatment Plans in Stereotactic Body Radiation Therapy (SBRT) for Lung Cancer Patients2025
  3. 3The role of SBRT as an ablative treatment in oligometastatic patients2026
  4. 4Stereotactic Body Radiotherapy of Colorectal Cancer Oligometastases to the Liver: Three Years Follow-Up2025
  5. 5Outcomes of stereotactic body radiotherapy for unresectable cholangiocarcinoma: a meta-analysis and systematic review2025